Trial Profile
A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Study to Investigate the Effects of Chronic Dose Oral GW406381 on Pain and Areas of Hyperalgesia and Allodynia in Patients With Peripheral Nerve Injury as a Result of Trauma or Surgery.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2023
Price :
$35
*
At a glance
- Drugs GW 406381 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 18 Sep 2014 New trial record